This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
1 Citations 8 Q&As
3 Citations 7 Q&As
Facts about Serum paraoxonase/arylesterase 1.
Mediates an enzymatic defense of low density lipoproteins against oxidative modification and the consequent series of events resulting in atheroma formation. .
Human | |
---|---|
Gene Name: | PON1 |
Uniprot: | P27169 |
Entrez: | 5444 |
Belongs to: |
---|
paraoxonase family |
A-esterase 1; Aromatic esterase 1; arylesterase B-type; EC 3.1.1.2; EC 3.1.1.81; EC 3.1.8.1; ESA; ESAesterase A; K-45; MVCD5; paraoxonase 1; PON 1; PON1; PONparaoxonase B-type; serum aryldiakylphosphatase; Serum aryldialkylphosphatase 1; serum paraoxonase/arylesterase 1
Mass (kDA):
39.731 kDA
Human | |
---|---|
Location: | 7q21.3 |
Sequence: | 7; NC_000007.14 (95297676..95324532, complement) |
Plasma, associated with HDL (at protein level). Expressed in liver, but not in heart, brain, placenta, lung, skeletal muscle, kidney or pancreas.
Secreted, extracellular space.
PMID: 1657140 by Hassett C., et al. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence.
PMID: 7916578 by Adkins S., et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
*More publications can be found for each product on its corresponding product page